Ticker Report Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) traded up 2.4% on Tuesday . The company traded as high as $1.10 and last traded at $1.09. 22,801 shares traded hands during trading, a...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nBright Minds Biosciences just reported results for the third quarter of 2024.\nThe post DRUG Stock Earnings: Bright Minds Biosciences...\n more…
Zolmax Avadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) and Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) are both small-cap medical companies, but which is the superior business? We will...\n more…
Ticker Report Bright Minds Biosciences (NASDAQ:DRUG - Get Free Report) and BeiGene (NASDAQ:BGNE - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies...\n more…
Ticker Report Bright Minds Biosciences Inc. (NASDAQ:DRUG - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling...\n more…